Amazon Begins Selling AI Shopping Technology to Retailers Attracts Kate Spade as Customer SpaceX Starship V3 Test Flight Marks Milestone for Commercial Space Sector Ebola Risk Escalation in DR Congo Potential Economic and Market Implications Average US Household Savings for Those in Their 50s A Reality Check Indian Markets Rally on Oil Price Decline and USIran Peace Optimism Dollar Slides as Oil Retreats on Strait of Hormuz Optimism Enpro Inc NPO Q1 2026 Earnings EPS Slightly Exceeds Estimates Shares Edge Higher CRNX Q1 2026 Earnings Narrowed Loss Per Share Slightly Below Expectations BWA Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Focus Allot Ltd Q1 2026 Earnings EPS Beat Drives Stock Higher Atkore ATKR Q1 2026 Earnings EPS Beats Estimates by 139 Amid Operational Strength PHM Q1 2026 Earnings Earnings Miss Estimates as Costs Outweigh Demand Forafric Global Warrants AFRIW Hold Steady at 075 Amid Quiet Trading Orrstown Financial Services ORRF Edges Higher With Measured Upside Potential Novanta Inc NOVT Rebounds Sharply Testing Key Resistance Zone Kairos Pharma Ltd KAPA Edges Lower as Stock Holds Key Support Zone Abony Acquisition Corp I Units Edge Lower as SPAC Units Trade Near Par Value ONBPP Q1 2026 Earnings Slight EPS Miss Amid Stable Performance Biogen BIIB Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction CCB Q1 2026 Earnings EPS Falls Short as Profitability Pressures Mount BEEM Q1 2026 Earnings EPS Misses Estimates as Beam Global Reports WiderThanExpected Loss Landstar System Inc LSTR Q1 2026 Earnings Modest EPS Beat Amidst Revenue Uncertainty AIZ Q1 2026 Earnings EPS Surges 113 Above Estimates Stock Edges Lower SpaceX Launches Redesigned Starship in Successful PreIPO Test EXP Q1 2026 Earnings Powerful EPS Beat Highlights Cost Discipline Amid Subdued Demand CG Oncology CGON Hovers Near Support Amid Modest Decline GBR Q3 2023 Earnings Small Profit Reported Stock Rises 177 Points UPXI Q1 2026 Earnings Significant EPS Miss Drives Stock Decline MNOV Q1 2026 Earnings SmallerthanExpected Loss Highlights ClinicalStage Value FSP Q4 2025 Earnings Significant EPS Beat Masks Revenue Disclosures IGC Q1 2026 Earnings Narrower Loss Signals Cost Discipline Despite Zero Revenue CLST Q3 2025 Earnings Net Income Strengthens Amid Steady Operational Focus WSM Q1 2026 Earnings Strong EPS Beat Amidst Challenging Retail Environment